Commentary

Video

Ask the Experts: What problem in ophthalmology do you wish there was a solution for?

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

Nathan Radcliffe, MD:

If I could have a solution to one problem in ophthalmology, it would certainly be some sort of cure for glaucoma. If I could really dream big, it would be a way to restore vision loss. There's never been a single patient who's lost vision from glaucoma who's gotten any of their vision back. It's an irreversible disease. I'd love to change that, and I used to tell people it'll never happen, but gosh, the science is advancing so rapidly these days that now I tell people, I think there's hope.

Victoria Tseng, MD, PhD:

I think probably other than with cataracts, everything else, we're trying to slow things down, but it'd be great if we could reverse things, especially for glaucoma, because that's where I work.

John Josephson, MD:

So what I wish there was a solution for in ophthalmology–there's so many things. But I think when I think about if I could solve one problem, it would be–I know this is going to sound, there's a lot of big problems. HSV keratitis, these patients, when they come in–again, I'm a cornea specialist, so maybe that's why. But HSV keratitis is one of those conditions where we can't control when it happens. We can't control the outcome. We have treatments for it, but it's really a strange condition because a lot of mimicrs of it. If we could put more effort into trying to figure out that condition and how to treat it and maybe even prevent it, I would be very happy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.